We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Here's what to know about the seven-story project and what it will include — as well as why this project is moving forward ...

The borough president and community boards approved the Atlantic Avenue Mixed-Use Proposal but with conditions, including ...

The merger agreement, titled the Agreement and Plan of Merger and Reorganization ... and commercializing therapeutics treatment of chronic pruritus in the United States. The company’s lead ...

Atossa Therapeutics, Inc. has provided a shareholder ... As we move into the randomized portion of the trial, we remain focused on building the evidence to support (Z)-endoxifen as a more ...

United Therapeutics could eventually use the genetically edited swine to grow organs for human transplant recipients. A public biotechnology company is planning a large project in northeast ...

SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ ... strategy given his track record with oncology agents and team-building expertise. With eight analysts recently revising earnings estimates ...

These statistics underscore the urgency of robust adaptation planning, central to which are National Adaptation Plans (NAPs). To date, 64 countries have submitted their NAPs to UN Climate Change, ...

Summit plans to report results from its first late ... However, Wall Street's enthusiasm for Summit Therapeutics appears to be justified. If ivonescimab fulfills its potential, Summit should ...

Getting there —and staying ahead of rival nations in the AI race — depends on a plan to transform the physical ... too compelling to forfeit" by not building the infrastructure needed.